Press release
Rising Genetic Disease Prevalence Driving Advances In Treatment And Research: A Key Driver Powering Tay-Sachs Disease Treatment Market Growth In 2025
Tay-Sachs Disease Treatment
What Is the Current Tay-Sachs Disease Treatment Market Size and Its Estimated Growth Rate?
In recent times, there has been a notable expansion in the market for Tay-Sachs disease treatment. The market, which was valued at $2.28 billion in 2024, is predicted to escalate to $2.45 billion in 2025, showing a compound annual growth rate (CAGR) of 7.5%. The historic growth of this market can be attributed to factors such as heightened genetic screening, increased focus on rare diseases, the upsurge in Tay-Sachs disease cases, the demand for superior healthcare, and a rise in chronic conditions.
Predictions suggest a robust increase in the market size of Tay-Sachs disease treatment in the upcoming years, with a projection to reach $3.25 billion by 2029, recording a Compound Annual Growth Rate (CAGR) of 7.3%. The forecasted expansion can be linked to factors such as the escalating rates of lysosomal storage disorders, heightened awareness campaigns, expansion of genetic testing services, increased demand for symptomatic remedies, and a rising incidence of genetic ailments. The period also foresees trends like progress in gene therapy, next-generation sequencing becoming cost-effective, automated cloning platforms, advancements in drug delivery mechanisms, the infusion of artificial intelligence and machine learning, as well as the uptake of telemedicine solutions.
Purchase the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=21295
How Are Emerging Segments Shaping the Tay-Sachs Disease Treatment Market Landscape?
The tay-sachs disease treatment market covered in this report is segmented -
1) By Treatment: Medication, Respiratory Care, Physical Therapy
2) By Mode Of Administration: Injectable, Oral, Other Mode Of Administration
3) By End-Users: Hospitals, Homecare, Specialty Clinics
Subsegments:
1) By Medication: Antiepileptic Drugs, Miglustat, Supportive Symptomatic Medications
2) By Respiratory Care: Mechanical Ventilation, Airway Clearance Therapy, Oxygen Therapy
3) By Physical Therapy: Motor Function Exercises, Hydrotherapy, Assistive Mobility Devices
Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=21295&type=smp
Which Growth Factors Are Influencing Tay-Sachs Disease Treatment Market Expansion?
The escalating incidence of genetic disorders is anticipated to propel the tay-sachs disease treatment market in the future. Genetic disorders are illnesses induced by anomalies in a person's DNA, which can be passed down through generations or occur as a result of spontaneous mutations. The rise in genetic diseases can be attributed to improvement in diagnostic techniques, increased consciousness, environmental influences, and increased mutation frequency due to postponed parenthood and alterations in lifestyle. The escalating incidence of genetic ailments underscores the necessity for enhancements in tay-sachs disease treatment, propelling research into gene therapy, enzyme replacement, and early diagnosis. For example, Genomics England, a government organization based in the UK, reported in February 2022 that over 7,000 known rare diseases affect about 1 in 17 people (3.5 million) in the UK. Consequently, the escalating incidence of genetic disorders is expected to fuel the tay-sachs disease treatment market.
Who Are the Dominant Players Across Different Tay-Sachs Disease Treatment Market Segments?
Major companies operating in the tay-sachs disease treatment market are Pfizer Inc., Sanofi S.A., Novartis AG, Takeda Pharmaceutical Company Limited, Regeneron Pharmaceuticals Inc., Biogen Inc., Vertex Pharmaceuticals Incorporated, BioMarin Pharmaceutical Inc., Sarepta Therapeutics Inc., Ultragenyx Pharmaceutical Inc., Amicus Therapeutics Inc., Spark Therapeutics Inc., Rocket Pharmaceuticals Inc., RegenxBio Inc., Forge Biologics Inc., Passage Bio Inc., Protalix BioTherapeutics Inc., Orchard Therapeutics plc, Affinia Therapeutics Inc., IntraBio Inc., Taysha Gene Therapies Inc.
What Are the Major Trends Shaping the Tay-Sachs Disease Treatment Market?
Leading entities in the Tay-Sachs disease treatment market are focusing on the development of novel treatments. This includes the execution of clinical trials to investigate the potential of revolutionary therapies like gene therapy, enzyme replacement, and small-molecule drugs to enhance patient results. Clinical trials are a research process used to determine the safety, effectiveness, and potential adverse reactions of medical procedures, drugs, or treatments in humans. For example, IntraBio Inc., a U.S. based biopharmaceutical company, in July 2024, declared it had been granted approval for its Investigational New Drug (IND) Application by the US Food and Drug Administration (FDA) to probe a clinical trial (IB1001-202) for IB1001, aimed at GM2 Gangliosidosis (Tay-Sachs and Sandhoff Disease). The trial, occurring in the U.S., UK, Germany and Spain, seeks to combat these deadly neurodegenerative diseases that are currently without any approved therapies. The chairman of IntraBio has highlighted the immediate need for the creation of effective treatments for these crippling diseases.
Get the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/report/tay-sachs-disease-treatment-global-market-report
Which Geographic Regions Are Expected to Dominate the Tay-Sachs Disease Treatment Market in the Coming Years?
North America was the largest region in the tay-sachs disease treatment market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the tay-sachs disease treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Frequently Asked Questions:
1. What Is the Market Size and Growth Rate of the Tay-Sachs Disease Treatment Market?
2. What is the CAGR expected in the Tay-Sachs Disease Treatment Market?
3. What Are the Key Innovations Transforming the Tay-Sachs Disease Treatment Industry?
4. Which Region Is Leading the Tay-Sachs Disease Treatment Market?
Why This Report Matters:
Competitive overview: This report analyzes the competitive landscape of the 3D imaging software market, evaluating key players on market share, revenue, and growth factors.
Informed Decisions: Understand key strategies related to products, segmentation, and industry trends.
Efficient Research: Quickly identify market growth, leading players, and major segments.
Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.
Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info
Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Rising Genetic Disease Prevalence Driving Advances In Treatment And Research: A Key Driver Powering Tay-Sachs Disease Treatment Market Growth In 2025 here
News-ID: 4071214 • Views: …
More Releases from The Business Research Company
Seed Treatment Fungicides Market to Grow at 9.3% CAGR, Reaching $3.15 Billion by …
Use ONLINE30 for 30% savings on global market reports and stay on top of tariff updates, market trends, and economic shifts worldwide.
Seed Treatment Fungicides Market Outlook: How is the Market Expected to Grow by 2025?
Over the past few years, the market for seed treatment fungicides has seen robust growth. Its market value is projected to rise from $2.07 billion in 2024 to $2.21 billion in 2025, signifying a compound annual…
Rheology Modifiers Market Growth to be Driven by Emerging Trends | $10.92 Billio …
Stay informed on tariff shifts, macro trends, and global economic changes-use code ONLINE30 to enjoy 30% off our global market reports.
What is the Projected Market Size of the Rheology Modifiers Industry?
There has been a consistent expansion in the size of the rheology modifiers market in the past few years. The market, which was worth $8.59 billion in 2024, is projected to increase to $8.89 billion in 2025, demonstrating a compound…
Polyurethane Foam Market to Record 8.4% CAGR Growth Through 2029 | Global Analys …
Use ONLINE30 for 30% savings on global market reports and stay on top of tariff updates, market trends, and economic shifts worldwide.
Polyurethane Foam Market Outlook: How is the Market Expected to Grow by 2025?
In recent years, the size of the polyurethane foam market has experienced substantial growth. It is projected to increase from a value of $54.27 billion in 2024 to $57.26 billion in 2025, indicating a compound annual growth…
Pharmaceutical Intermediates Market Size to Reach $46.04 Billion by 2029 | Growt …
Stay informed on tariff shifts, macro trends, and global economic changes-use code ONLINE30 to enjoy 30% off our global market reports.
What is the Projected Market Size of the Pharmaceutical Intermediates Industry?
There has been consistent growth in the market size of pharmaceutical intermediates over the past few years. The market is predicted to increase from a value of $33.37 billion in 2024, up to $34.95 billion in 2025, with a compound…
More Releases for Disease
Protheragen Announces Disease Model Development Services to Enhance Rare Disease …
Protheragen announced the release of its disease model development services provided to enhance rare disease research. With an increasing focus on rare diseases and the need for tailored research models, Protheragen is dedicated to providing cutting-edge solutions to support this important area of medical research.
Rare diseases, which affect a small percentage of the population, pose unique challenges for researchers due to their limited understanding and lack of available treatment options.…
Biopharmaceutical Fermentation Market 2022 | Growing Morbidity of Genetic Diseas …
According to Precision Business Insights (PBI), the latest report, the biopharmaceutical fermentation market is expected to be valued at USD 10,302.1 million in 2022, growing at a 4.7% CAGR from 2022 to 2028. The growing prevalence of chronic illness, cancer, cardiac diseases, infectious diseases, antibiotic resistance, autoimmune diseases, etc., globally causes the leaning toward biopharmaceutical products, which show promising results in the research studies. Moreover, new findings by the…
Global Inflammatory Bowel Disease (IBD) Market Key Players Analysis, Disease Ind …
Global Inflammatory Bowel Disease (IBD) Market, valued at USD 210.5 Billion in the year 2020 has been driven by factors such as the increasing prevalence of Ulcerative Colitis and Crohn’s Disease, advances in medical technology, government support for inflammatory bowel disease treatment research, and the ubiquity of anxiety and depression. Moreover, factors such as the irregular food habits, unhealthy lifestyle of people, increased level of pollution and increase in alcohol…
Moyamoya Disease Market - A Scientometric Assessment of Disease During 2018-23
Market Highlight:
Moyamoya disease (MMD) is a chronic, cerebrovascular disease characterized by progressive stenosis in the internal carotid artery and an abnormal vascular network at the base of the brain. The stroke is one of the significant symptoms of moyamoya disease, which further leads to paralysis of the face, arms, and legs, loss of speech, and temporary loss of neurologic function of body parts, visual disturbances, headaches, developmental delay, and…
Refsum Disease Industry An Overview of A New Disease - 2018
"Refsum Disease" is a genetic disorder which is inherited as an autosomal recessive trait. The condition is characterized by progressive loss of vision (retinitis pigmentosa), failure of muscle coordination (ataxia), degenerative nerve disease (peripheral neuropathy), and dry, rough, scaly skin (ichthyosis). The accumulation of fatty acid (phytanic acid) in blood plasma and tissues is the main cause of refsum disease. This occurs due to malfunction of the enzyme producing gene…
Chagas Disease (Infectious Disease) Pipeline Forecast Report, H1, 2017 [MRH]
Market Research Hub's Pharmaceutical and Healthcare latest pipeline guide Chagas Disease - Pipeline Review, H1 2017, provides comprehensive information on the therapeutics under development for Chagas Disease Market (Infectious Disease), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and…
